In addition, bright liver was common in these patients, and increased expression of ACE2 in non-alcoholic fatty liver disease has been reported previously.13 These observations suggest that the main mechanism of elevation of liver enzyme levels is not “bystander hepatitis” or medication, but rather the effect of COVID-19 itself. This evidence concerns the gene ACE2 and metabolic dysfunction-associated steatotic liver disease.